April 13, 2012 — The bladder holds a world of bacteria that do not show up in standard cultures, regardless of whether a woman has symptoms of a urinary tract infection, according to a study published ...

This infographic highlights the principles, strengths and limitations of qPCR while showcasing its applications across fields ...

Early on-treatment (on-Rx) tumor volume reduction (TVR) to predict response to the KEYNOTE-522 (KN-522) regimen in early stage triple negative breast cancer (TNBC).

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...

Adding carboplatin to standard neoadjuvant chemotherapy improves overall survival in TNBC, but the benefit is only ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced that ...